OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0000919745

Midatech Pharma US Inc.

Midatech Pharma US Inc. (CIK 0000919745, EIN 04-3216862) reported revenue of $1.89 million ($1,886,507) for FY2014 (2014-01-01 to 2014-12-31) and net income of -$9 million (-$9,001,127) for FY2014 (2014-01-01 to 2014-12-31), as filed in its 10-K filed 2015-03-03 (accession 0001214659-15-001939).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0000919745
EIN04-3216862
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categorySmaller reporting company
Entity typeoperating
Olympus entity IDorg_4ma7fnna3xkc6crgzzyy317sk8
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$1,886,507FY20142014-01-01 to 2014-12-3110-K2015-03-030001214659-15-001939Revenues
Net income-$9,001,127FY20142014-01-01 to 2014-12-3110-K2015-03-030001214659-15-001939NetIncomeLoss
Total assets$17,752,495FY2014as of 2014-12-3110-K2015-03-030001214659-15-001939Assets
Total liabilities$3,836,364FY2014as of 2014-12-3110-K2015-03-030001214659-15-001939Liabilities
Stockholders' equity$13,916,131FY2014as of 2014-12-3110-K2015-03-030001214659-15-001939StockholdersEquity
Operating cash flow-$7,986,814FY20142014-01-01 to 2014-12-3110-K2015-03-030001214659-15-001939NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.63 per shareFY20142014-01-01 to 2014-12-3110-K2015-03-030001214659-15-001939EarningsPerShareBasicAndDiluted
Shares outstanding19,755,595 sharesFY2014as of 2015-02-2610-K2015-03-030001214659-15-001939EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2005-2014, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20142014-01-01 to 2014-12-31$1,886,50710-K2015-03-030001214659-15-001939
RevenueFY20132013-01-01 to 2013-12-31$419,32210-K2015-03-030001214659-15-001939
RevenueFY20122012-01-01 to 2012-12-31$53,62910-K2014-02-040001354488-14-000445
Net incomeFY20142014-01-01 to 2014-12-31-$9,001,12710-K2015-03-030001214659-15-001939
Net incomeFY20132013-01-01 to 2013-12-31-$9,965,01410-K2015-03-030001214659-15-001939
Net incomeFY20122012-01-01 to 2012-12-31-$7,311,03310-K2014-02-040001354488-14-000445
Net incomeFY20112011-01-01 to 2011-12-31-$6,170,58810-K2013-03-280001354488-13-001531

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2015-11-022015-09-300001214659-15-007367j102315010q.htm
10-Q2015-08-122015-06-300001214659-15-005994b8615010q.htm
10-Q2015-05-132015-03-310001214659-15-003906a5615010q.htm
10-K2015-03-032014-12-310001214659-15-001939s22615110k.htm
10-Q2014-11-052014-09-300001214659-14-007437c102914010q.htm
10-Q2014-08-122014-06-300001214659-14-005801a8514010q.htm
10-Q2014-05-122014-03-310001354488-14-002447dara_10q.htm
10-K2014-02-042013-12-310001354488-14-000445dara_10k.htm
10-Q2013-11-132013-09-300001354488-13-006246dara_10q.htm
10-Q2013-08-142013-06-300001354488-13-004535dara_10q.htm
10-Q2013-05-152013-03-310001354488-13-002864dara_10q.htm
10-K2013-03-282012-12-310001354488-13-001531dara_10k.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0000919745published by the sourcedata.sec.gov/submissions/CIK0000919745.json2026-10-21
Employer Identification Number (EIN) · US-EIN04-3216862published by the sourcedata.sec.gov/submissions/CIK0000919745.json2026-10-21

Former names

NameFromTo
DARA BioSciences, Inc.2008-02-252015-12-02
DARA BIOSCIENCES INC2007-12-062008-02-25
POINT THERAPEUTICS INC2002-04-012008-02-11
HMSR INC2001-11-152002-02-11
HEMASURE INC1996-05-162001-05-15

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0000919745.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0000919745.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000919745" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000919745/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000919745/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"919745"}

On SEC EDGAR

About this data